Fresenius Kabi Oncology Ltd. | FKONCO | NSE - Pharmaceuticals


Performance  |  Valuation  |  Growth  |  Insiders  |  Summary
Balance Sheet  |  Income Statement  |  Cash Flow  |  Quarterly

Financial Summary Report of Fresenius Kabi Oncology Ltd.



FKONCO
Fresenius Kabi Oncology Ltd.

Rs. 132.50
02-Jan-2014

5 Yr Performance

1 Yr Performance

Valuation



Analysis


Upgrade to Professional Membership

Quarterly Revenue, Net Income and Adjusted Share Price



Upgrade to Professional Membership

Peer Comparison


AstraZenca Pharma India Ltd.

Aurobindo Pharma Ltd.

Biocon Ltd.

Cadila Healthcare Ltd.

Cipla Ltd.

RPG Life Sciences Limited

Divis Laboratories Ltd.

Dr. Reddy's Laboratories Ltd.

FDC Ltd.

Glaxosmithkline Pharmaceuticals Ltd.